| Due Diligence for Asset Managers |
|---|
|
You have viewed 10 of the 10 daily limit Subscribe for $29/month to gain full access |
|
⚲
|
| Keyboard |
| CVRX Inc | |
|---|---|
| Ticker | CVRX |
| CIK # | 0001235912 |
| CUSIP | 126638105 |
| Sector | Life Sciences - Surgical & Medical Instruments & Apparatus |
| Address | 9201 West Broadway Avenue Suite 650, Minneapolis, MN 55445 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| CVRX Inc | 2020-07-08 | 50.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001235912] | 10-K | |
| [0001235912] | 10-Q | |
| [0001235912] | 3 | |
| [0001235912] | 4 | |
| [0001235912] | 8-K | |
| [0001235912] | D | |
| [0001235912] | SC 13D | |
| [0001235912] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| GSK PLC | CVRX Inc | [2023-02-06] | 4.9 |
| Soleus Capital Master Fund LP | CVRX Inc | [2022-04-29] | 5.1 |
| Vensana Capital I GP LLC | CVRX Inc | [2022-02-10] | 7.2 |
| Johnson & Johnson | CVRX Inc | [2022-02-07] | 19.6 |
| New Enterprise Associates 10 L P | CVRX Inc | [2021-07-15] | 11.4 |
| GlaxoSmithKline PLC | CVRX Inc | [2021-07-12] | 5.0 |
| Cooperatieve Gilde Healthcare IV UA | CVRX Inc | [2021-07-12] | 0.0 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Verrastro Paul
Common Stock
|
2026-03-02 | Sell | 1,284 | $7.90 | 10,144 |
|
Morrison Gregory
Common Stock
|
2026-03-02 | Grant | 34,000 | $0.00 | |
|
Hykes Kevin
Common Stock
|
2026-03-02 | Sell | 7,763 | $7.90 | 61,328 |
|
Morrison Gregory
Stock Option (right to buy) · derivative
|
2026-03-02 | Grant | 154,500 | $0.00 | |
|
Oasheim Jared
Common Stock
|
2026-03-02 | Sell | 1,744 | $7.90 | 13,778 |
|
Adamson Philip B
Common Stock
|
2026-03-02 | Sell | 1,262 | $7.90 | 9,970 |
|
John Robert Allen
Common Stock
|
2026-03-02 | Sell | 3,964 | $7.90 | 31,316 |
|
Oasheim Jared
Common Stock
|
2026-02-27 | Grant | 61,000 | $0.00 | |
|
John Robert Allen
Stock Option (right to buy) · derivative
|
2026-02-27 | Grant | 52,000 | $0.00 | |
|
John Robert Allen
Common Stock
|
2026-02-27 | Grant | 35,000 | $0.00 | |
|
Verrastro Paul
Stock Option (right to buy) · derivative
|
2026-02-27 | Grant | 67,000 | $0.00 | |
|
Adamson Philip B
Common Stock
|
2026-02-27 | Grant | 41,000 | $0.00 | |
|
Oasheim Jared
Stock Option (right to buy) · derivative
|
2026-02-27 | Grant | 91,000 | $0.00 | |
|
Binkowski Brent
Common Stock
|
2026-02-27 | Grant | 15,000 | $0.00 | |
|
Hykes Kevin
Common Stock
|
2026-02-27 | Grant | 159,000 | $0.00 | |
|
Hykes Kevin
Stock Option (right to buy) · derivative
|
2026-02-27 | Grant | 238,000 | $0.00 | |
|
Adamson Philip B
Stock Option (right to buy) · derivative
|
2026-02-27 | Grant | 62,000 | $0.00 | |
|
Binkowski Brent
Stock Option (right to buy) · derivative
|
2026-02-27 | Grant | 23,000 | $0.00 | |
|
Verrastro Paul
Common Stock
|
2026-02-27 | Grant | 45,000 | $0.00 | |
|
Jain Mudit K
Common Stock
|
2026-02-20 | Buy | 46,800 | $6.36 | 297,648 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 100 | 14,737,310 |
| 2025-12-31 | 92 | 15,241,986 |
| 2025-09-30 | 93 | 14,126,867 |
| 2025-06-30 | 93 | 14,654,207 |
| 2025-03-31 | 98 | 16,150,789 |
| 2024-12-31 | 95 | 15,237,152 |
| 2024-09-30 | 86 | 14,350,584 |
| 2024-06-30 | 74 | 13,250,302 |
| 2024-03-31 | 89 | 14,827,572 |
| 2023-12-31 | 84 | 13,334,464 |
| 2023-09-30 | 64 | 11,717,717 |
| 2023-06-30 | 69 | 11,783,427 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Gamma Investing LLC | [2026-06-30] | DFND | 1,049 | 1,049 |
| Thurston Springer Miller Herd & Titak Inc | [2026-06-30] | SOLE | 225 | 225 |
| True Wealth Design LLC | [2026-06-30] | SOLE | 0 | 174 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 37 |
| Versant Capital Management Inc | [2026-06-30] | SOLE | 35 | 35 |
| IFP Advisors LLC | [2026-06-30] | SOLE | 18 | 18 | Prev | Page 1 | Next |